Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis

Journal of Neuroimmunology

Volumn 86, Issue 2, 1998, Pages 151-154

  Zipp, Frauke ^a   Otzelberger, Karin ^a   Dichgans, Johannes ^a   Martin, Roland ^b   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis; Autoimmune disease; CD95; Multiple sclerosis

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL;

ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; GLIOMA; HUMANS; MULTIPLE SCLEROSIS; RECURRENCE; SOLUBILITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032525797     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00032-0     Document Type: Article

References (30)

1. Alderson M.R., Tough T.W., Davis-Smith T., Braddy S., Falk B., Schooley K.A., Goodwin R.G., Smith C.A., Ramsdell F., Lynch D.H. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:1995;71-77.
2. Bonetti B., Raine C.S. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
3. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubl A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F., Green D.R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature. 373:1995;441-444.
4. Cascino I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:1995;2706-2713.
5. Cascino I., Papoff G., De Maria R., Testi R., Ruberti G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 156:1996;13-17.
6. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
7. Correale J., Gilmore W., Lopez J., Li S.Q., McMillan M., Weiner L.P. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nature Med. 2:1996;1354-1360.
8. Critchfield J.M., Racke M.K., Zúñiga-Pflücker J.C., Cannella B., Raine C.S., Goverman J., Lenardo M.J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1994;1139-1143.
9. Dhein J., Walczak H., Bäumler C., Debatin K.M., Krammer P.H. Autocrine T cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438-441.
10. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
11. Dowling P., Husar W., Menonna J., Donnenfeld H., Cook S., Sidhu M. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 149:1997;1-11.
12. D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
13. Inoue A., Koh C., Sakai T., Yamazaki M., Yanagisawa N., Usuku K., Osame M. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. J. Neuroimmunol. 75:1997;141-146.
14. Ju S.T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T cell-activation. Nature. 373:1995;444-448.
15. Knipping E., Debatin K.M., Stricker K., Heilig B., Eder A., Krammer P.H. Identification of soluble APO-1 in supernatants of human B and T cell leukemias. Blood. 85:1995;1562-1569.
16. Malipiero U., Frei K., Spanaus K.S., Agresti C., Lassmann H., Hahne M., Tschopp J., Eugster H.P., Fontana A. Myelin oligodendrocyte glycoprotein-induced encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27:1997;3151-3160.
17. Papoff G., Cascino I., Eramo A., Starace G., Lynch D.H., Ruberti G. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol. 156:1996;4622-4630.
18. Pender M.P., Nguyen K.B., McCombe P.A., Kerr J.F.R. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:1991;81-87.
19. Rodriguez M., Karnes W.E., Bartleson J.D., Pineda A.A. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 43:1993;1100-1104.
20. Roth W., Fontana M., Trepel M., Dichgans J., Reed J.C., Weller M. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. Cancer Immunol. Immunother. 44:1997;55-63.
21. Sabelko K.A., Kelly K.A., Nahm M.H., Cross A.H., Russell J.H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:1997;3096-3099.
22. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:1993;446-452.
23. Vamvakas E.C., Pineda A.A., Weinshenker B.G. Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis. J. Clin. Apheresis. 10:1995;163-170.
24. Van Parijs L., Ibraghimov A., Abbas A.K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:1996;321-328.
25. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:1997;3100-3103.
26. 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24:1994;1293-1300.
27. Weller M., Frei K., Groscurth P., Krammer P.H., Yonekawa Y., Fontana A. Anti Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:1994;954-964.
28. Weller M., Malipiero U., Rensing-Ehl A., Barr P.J., Fontana A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 55:1995;2936-2944.
29. Zipp F., Martin R., Lichtenfels R., Roth W., Dichgans J., Krammer P.H., Weller M. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J. Immunol. 159:1997;2108-2115.
30. Zipp F., Weller M., Calabresi P.A., Frank J.A., Bash C.N., Dichgans J., McFarland H., Martin R. Increased serum levels of soluble CD95 (APO1/Fas) in relapsing remitting multiple sclerosis. Ann. Neurol. 43:1998;116-120.